Executive Management

Buddy G. Beck

Founder & CEO

Buddy shares his wisdom with D3D as an industrial entrepreneur, business executive, scholar, public servant, inventor, and technologist. His notable career includes years of distinguished military and public service, including time served on the National Security Council staff in the White House under Presidents Ford and Carter. Early in his career Buddy founded Atlantic Systems Research & Engineering (ASR&E), which began his journey to the top of corporate America. ASR&E later merged with Coleman Research Corporation (CRC) which, under Buddy’s leadership, was recognized in 1993 by Business Week as the fastest growing small, private technology company in the United States. In 1995 Buddy led CRC’s merger with Thermo Electron Corporation. In 2000 Buddy founded Trans Digital Technologies Corporation (TDT) and served as President, CEO, and majority shareholder until the company was acquired by Viisage Technologies. This notable acquisition further launched Buddy to the highest corporate ranks as Viisage became known as L-1 Identity Solutions, selecting Buddy to serve as Vice Chairman of the Board of Directors in the multibillion dollar corporation. Buddy currently sits on the boards of multiple other public and private companies, serves on a number of national security boards, and is deeply involved with many non-profit organizations. He established The Beck Foundation, a foundation which has created research programs at top universities nationwide.

Robert E. Douglas Ph.D.

Founder & CTO

Dr. Robert E. Douglas, Ph.D. has over 30 years’ experience in analysis of challenging operational and technical problems facing DoD and DHS.  His expertise and leadership ability has been recognized at the National level. Dr. Douglas is currently President of Douglas Analytic Services. Their focus of activities has been modelling and simulation of advanced sensors. Dr. Douglas previously served as Vice President of Engineering at DRS Technologies. Dr. Douglas’ areas of responsibility included analyzing gaps in current force capabilities, formulating concepts for new systems, and developing new systems that meet defense and homeland security requirements. Prior to his tenure at DRS, Dr. Douglas served as the Director for Systems Analysis at Lockheed Martin. There he directed both broad and detailed technical studies. Dr. Douglas has extensive experience as a US Army Officer. He was Under Secretary of Air Force Space Systems, Commander of the Computer Center, and a military observer in the Middle East for the United Nations. Dr. Douglas has served on a number of private and public boards. He currently serves as a member of the Army Science Board. Dr. Douglas graduated from the United States Military Academy in Engineering. He received his Ph.D. in Operations Analysis from the University of Central Florida.

Frank McCaney

Director of Commercialization

Frank J. McCaney is President and CEO of Strata Skin Sciences, Inc. (SSKN:NASDAQ). From 2013 to 2016 he served as CEO of Corpak MedSystems, a private equity backed enterprise, until it was sold to Halyard Health. Previous to Corpak Mr. McCaney was the founder and CEO of Nitric BioTherapeutics, a drug delivery start-up. He was also involved in the spin-out of VIASYS Healthcare Inc. (VAS:NYSE) from Thermo Electron. VIASYS was sold to Cardinal Health in 2007. Mr. McCaney is a Biochemist by training and has worked in the medical device industry for more than 30 years from R&D and Sales to positions of increasing responsibility. He also serves on the Board of Diasome Pharmaceuticals.

Vice President of

Operations

Demetri Venets

Demetri Venets is Vice President of Operations for D3D Technoloy. He oversees day-to-day operations by strategic planning, directing, and developing strong relationships with outside partners. Demetri has a background in investment strategy, business development, and holds a degree in accounting from George Mason University. 

Medical Science Board

David Douglas, M.D.

Founder & Chairman of the Medical Science Board

Dr. David Douglas is the primary inventor of D3D technology.  He majored in Physics at the US Air Force Academy, completed a M.D. from Georgetown and a M.P.H. from Harvard University. His post-graduate training included General Surgery Internship and Diagnostic Radiology Residency at the University of California, Davis. Then, he went to Stanford University where he was the first ever neuroradiology fellow to complete dual neuroradiology-nuclear medicine fellowships. He is now a dual board certified neuroradiologist-nuclear medicine physician licensed in California. He is the senior author on 6 of D3D’s peer-reviewed publications where we have demonstrated D3D proof-of-concept on D3D involving multiple different head display units and multiple different types of cross-sectional imaging including CT, MRI and PET. He has also delivered talks at two international scientific conferences and presented D3D’s proof-of-concept prototype and initial results. 

MG Elder Granger, M.D.

Medical Science Board

Major General Granger is currently the President and CEO of THE 5Ps, LLC, a health care, education, and leadership organization. Prior to his retirement from the US Army, Granger served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs), from December 2005 to May 2009. In this role, he was the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DOD health plan policy and performance. He oversaw the acquisition, operation, and integration of TRICARE/DOD’s managed care program within the Military Health System. MG Granger led a staff of 1,800 in planning, budgeting and executing a $22.5 Billion Defense Health Program. Prior to joining TRICARE Management Activity, MG Granger led the largest U.S. and multi-national battlefield health system in our recent history while serving as Commander. He has led at every level of the Army Medical Department. MG Granger has received numerous awards, decorations and honors, including the Defense Superior Service Medal, the Legion of Merit with three oak leaf clusters, the Bronze Star Medal, and the Meritorious Service Medal with four oak leaf clusters. He is board-certified by the American Board of Internal Medicine and the Board of Hematology and Oncology, certified Physician Executive by the Certifying Commission in Medical Management, certified by the American College of Healthcare Executives, and Certified in Medical Quality by the American Board of Medical Quality. CERT-certificate in Cybersecurity Oversight from Carnegie Mellon University. He earned a Bachelor of Science degree from Arkansas State University in 1976. A Distinguished Military Graduate, MG Granger was commissioned through the Reserve Officer Training Corps. Upon graduation from the University of Arkansas School Of Medicine in 1980, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. MG Granger completed a residency in Internal Medicine in 1983 and a fellowship in Hematology-Oncology in 1986 at Fitzsimons Army Medical Center. Granger was awarded an honorary Doctor of Science Degree from Meharry Medical College in 2009.

Craig E. Cheifetz, MD

Medical Science Board

Craig Cheifetz, MD, FACP, is the VP, Corporate Health and Premium Services for Inova Health Systems. Dr. Cheifetz is the Regional Dean of Virginia Commonwealth University School of Medicine Inova Campus and Director of the Inova Office of Undergraduate Medical Education. He has received several “Golden Apple” teaching awards. Dr. Cheifetz has been an integral part of Inova and the Inova Fairfax Hospital medical staff for more than 15 years. He was recognized in 2012 for outstanding achievement by the American College of Physicians when he received the Walter J. McDonald Award for Young Physicians. He was also the 2011-2013 Chair of the AAMC Group on Regional Medical Campuses, which represents the interests of regionally located medical schools in the United States and Canada. Dr. Cheifetz received his medical degree from the State University of New York at Buffalo, where he received the Philip P. Sang award for outstanding communicator with patients, faculty and staff. He completed his internal medicine training at Georgetown School of Medicine, earning the ACP Donald Steinweg award for outstanding resident clinician and educator. Dr. Cheifetz is one of a select few medical educators certified by Stanford School of Medicine to teach other doctors how to teach. He also received the United Nations Association of the National Capital Area Human Rights Award for his work with political refugees. 

Lance Liotta, M.D.

Medical Science Liaison  

Dr. Liotta is currently Co-Director for the Center for Applied Proteomics and Molecular Medicine at GMU. He also is Professor at the Department of Molecular and Microbiology at GMU. Dr. Liotta has over 30 years of experience in medical research and development. Previous positions held include: Deputy Director for Research, NIH, Co-Director NCI/FDA Clinical Proteomics Program, Director Anatomic Pathology Residency Program, Laboratory of Pathology (National Cancer Institute, NIH), Chief, Laboratory of Pathology (National Cancer Institute, NIH), Chief, Tumor Invasion and Metastases Section (Laboratory of Pathology, NCI, NIH). While at the NIH, Dr. Liotta was the Director of the CAP/CLIA Laboratory for Anatomic Pathology, and held the CAP license for nearly 15 years. Dr. Liotta holds a B.S., Ph.D., and M.D. from Case Western Reserve University. Dr. Liotta currently has over 608 peer reviewed publications and in excess of 90 patents issued and/or allowed.